| A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL (NCT04984356) | Allotera Therapeutics | 2022-01-14 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies (NCT04195633) | Fred Hutchinson Cancer Center | 2021-01-25 |
| Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) (NCT04942730) | St. Petersburg State Pavlov Medical University | 2021-01-21 |
| SARS-CoV-2 Donor-Recipient Immunity Transfer (NCT04666025) | City of Hope Medical Center | 2020-09-23 |
| Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT04060277) | City of Hope Medical Center | 2019-11-27 |
| Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant (NCT03779854) | Fred Hutchinson Cancer Center | 2019-08-29 |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) (NCT03792256) | Children's Oncology Group | 2019-04-11 |
| CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT (NCT03810196) | Children's Hospital of Philadelphia | 2019-03-01 |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma (NCT03328104) | Emory University | 2018-07-24 |
| Study of Prognostic Factors in Adult Lymphoblastic Lymphoma (NCT03571997) | PETHEMA Foundation | 2018-06-15 |
| Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders (NCT03314974) | Masonic Cancer Center, University of Minnesota | 2018-03-30 |
| A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma (NCT03181126) | AbbVie | 2017-11-27 |
| High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma (NCT03178617) | City of Hope Medical Center | 2017-10-12 |
| Allo HSCT Using RIC for Hematological Diseases (NCT02661035) | Masonic Cancer Center, University of Minnesota | 2017-03-09 |
| Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT03023046) | University of Washington | 2017-02-23 |
| Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02960646) | M.D. Anderson Cancer Center | 2017-01-18 |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases (NCT01962636) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors (NCT02938741) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2016-10-01 |
| Thiopurine EnhAnced Maintenance Therapy (NCT02912676) | Kjeld Schmiegelow | 2016-10-01 |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment (NCT02881086) | Goethe University | 2016-08-01 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL (NCT03564704) | Nanfang Hospital, Southern Medical University | 2016-02-14 |
| LBL-2016 for Children or Adolescents in China (NCT02845882) | Children's Cancer Group, China | 2016-01-01 |
| Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant (NCT02506933) | City of Hope Medical Center | 2015-12-21 |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT02419469) | M.D. Anderson Cancer Center | 2015-11-13 |
| A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma (NCT01614197) | Therapeutic Advances in Childhood Leukemia Consortium | 2015-07-03 |
| Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults (NCT02535806) | Children's Mercy Hospital Kansas City | 2015-07-01 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD (NCT02220985) | Fred Hutchinson Cancer Center | 2015-03-23 |
| Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults (NCT02228772) | Massachusetts General Hospital | 2014-12-01 |
| A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) (NCT02257684) | Jazz Pharmaceuticals | 2014-09-01 |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (NCT01790152) | Children's Oncology Group | 2014-03-05 |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies (NCT01163201) | Masonic Cancer Center, University of Minnesota | 2014-01-01 |
| L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL (NCT01910428) | ERYtech Pharma | 2013-10-01 |
| Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma (NCT01943682) | Children's Hospital Medical Center, Cincinnati | 2013-09-01 |
| ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors (NCT02290132) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2013-08-01 |
| Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia (NCT01842672) | New York Medical College | 2013-03-01 |
| Acute Lymphoblastic Leukemia Registry at Asan Medical Center (NCT01761682) | Asan Medical Center | 2013-01-01 |
| A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy (NCT01643408) | Jazz Pharmaceuticals | 2012-11-01 |
| SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (NCT01574274) | Dana-Farber Cancer Institute | 2012-06-01 |
| NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma (NCT01451515) | St. Jude Children's Research Hospital | 2012-05-25 |
| Osteonecroses in Pediatric Patients With ALL (NCT01619124) | Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu | 2012-03-01 |
| Safety and Tolerability of HSC835 in Patients With Hematological Malignancies (NCT01474681) | Novartis Pharmaceuticals | 2012-01-09 |
| Hyper-CVAD Treatment in Lymphoblastic Lymphoma (NCT01813344) | Ajou University School of Medicine | 2012-01-01 |
| Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia (NCT01513603) | New York Medical College | 2012-01-01 |
| Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT01363128) | M.D. Anderson Cancer Center | 2011-07-12 |
| A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy (NCT01184885) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2010-07-01 |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors (NCT01100658) | University of Minnesota | 2010-05-01 |
| Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders (NCT01177527) | Dana-Farber Cancer Institute | 2009-12-30 |
| Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients (NCT00949741) | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | 2009-07-01 |
| Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters (NCT00882011) | Fondazione Italiana Linfomi - ETS | 2009-04-01 |
| Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma (NCT00866749) | M.D. Anderson Cancer Center | 2006-09-12 |
| Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients (NCT00412243) | M.D. Anderson Cancer Center | 2006-03-01 |
| Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease (NCT00719888) | Fred Hutchinson Cancer Center | 2005-11-18 |
| Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults (NCT00199082) | Nicola Goekbuget | 2002-07-01 |
| Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders (NCT00587054) | Memorial Sloan Kettering Cancer Center | 2001-06-01 |
| Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma (NCT00187122) | St. Jude Children's Research Hospital | 1993-03-01 |
| Expanded Access to Navitoclax (NCT03592576) | AbbVie | |
| JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase (NCT04943952) | Jazz Pharmaceuticals | |